Other OTC - Delayed Quote • USD
Acutus Medical, Inc. (AFIB)
At close: May 14 at 3:59 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | 0.41 | -0.57 | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | 35.36M |
| Low Estimate | 6.63M | 6.81M | 20.8M | 35.36M |
| High Estimate | 6.63M | 6.81M | 20.8M | 35.36M |
| Year Ago Sales | 4.96M | 4.17M | 16.36M | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 12/31/2022 | 3/31/2023 | 6/30/2023 | 9/30/2023 |
|---|---|---|---|---|
| EPS Est. | -0.71 | -0.69 | -0.64 | -0.61 |
| EPS Actual | 0.41 | -0.57 | -0.63 | -0.45 |
| Difference | 1.12 | 0.12 | 0.01 | 0.16 |
| Surprise % | 157.70% | 17.40% | 1.60% | 26.20% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | -0.62 | -0.57 | -2.48 | -2.19 |
| 30 Days Ago | -0.62 | -0.57 | -2.48 | -2.19 |
| 60 Days Ago | -0.62 | -0.57 | -2.48 | -2.19 |
| 90 Days Ago | -0.62 | -0.57 | -2.48 | -2.19 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | AFIB | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 7.30% |
| Next Qtr. | -- | -- | -- | 10.90% |
| Current Year | -- | -- | -- | 4.60% |
| Next Year | -- | -- | -- | 13.00% |
| Next 5 Years (per annum) | -- | -- | -- | 10.89% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Goldman Sachs: Neutral | 8/16/2022 |
| Maintains | BTIG: Buy | 6/24/2022 |
| Upgrade | BTIG: Neutral to Buy | 4/27/2022 |
| Maintains | Goldman Sachs: Neutral | 4/14/2022 |
| Downgrade | BTIG: Buy to Neutral | 1/20/2022 |
| Downgrade | Canaccord Genuity: Buy to Hold | 1/14/2022 |
Related Tickers
NUWE Nuwellis, Inc.
0.2304
-7.17%
TIVC Tivic Health Systems, Inc.
0.5000
+3.35%
SINT Sintx Technologies, Inc.
0.0550
+41.75%
BIOL BIOLASE, Inc.
0.1540
-14.87%
HSDT Helius Medical Technologies, Inc.
1.5600
-8.24%
NUVO Holdco Nuvo Group D.G Ltd
2.2200
-5.53%
TMCI Treace Medical Concepts, Inc.
5.0000
+10.38%
AEMD Aethlon Medical, Inc.
0.8501
-14.47%
SRTS Sensus Healthcare, Inc.
5.30
-1.85%
HSCS Heart Test Laboratories, Inc.
0.0791
+12.04%